Tenecteplase Injection

Get a Price/Quote

MOQ : 10 Boxes

Tenecteplase Injection Specification

Application
Hospital, Clinic, Prescription use

Purity
99%

CAS No
193153-04-7

Molecular Formula
C2658H4040N746O781S40

Grade
Pharmaceutical Grade

Formulations Type
Injectables

Formulations Form
Liquid

Treatments & Functions
Thrombolytic agent for acute myocardial infarction

Gender/Age Group
Adult

Dosage Guidelines
As directed by physician

Volume
5 ml

Storage Instructions
Store in Cool

Tenecteplase Injection Trade Information

Minimum Order Quantity
10 Boxes

FOB Port
NHAVA SHEVA

Payment Terms
Paypal, Letter of Credit (L/C), Western Union, Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
1000 Boxes Box Per Month

Delivery Time
30 Days

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
As Per Buyer Requirements

Main Domestic Market
All India

Certifications
ISO, GMP, WHO, FDA

About Tenecteplase Injection

Tenecteplase Injection

Product Description
We are known as the trusted entity in the entire pharmaceutical industry, successfully engaged in exporting excellent quality Tenecteplase Injection. This Tenecteplase Injection is indicated for use in the reduction of mortality that is associated with acute myocardial infarction. Procured from reputed vendors in the market, this Tenecteplase Injection is formulated in complete compliance with FDA norms using supreme quality compounds. We are offering this Tenecteplase Injection to clients at the feasible price.

Key points:

This medication is used during the early stages of a heart attack
It belongs to a group of medicines called tissue plasminogen activators (t-PA)
It dissolves the clots formed in blood vessels that can cause disease by interfering with normal blood flow

Specifications:

Brand: Metalyse
Contain: Tenecteplase Injection
Strength : 40mg
Packing: Vail.
Company: Boehringer Ingelheim
Use: Cardiovascular Medication

Uses: Tenecteplase is used for mortality reduction associated with an acute heart attack (myocardial infarction) within 6 hours after the symptoms have started.

Fast-Acting Thrombolytic Therapy

Tenecteplase Injection offers swift intervention for patients experiencing acute myocardial infarction. By targeting and dissolving thrombi in coronary arteries, TNKase improves outcomes and minimizes heart tissue damage. Its specialized formulation is designed for timely administration in clinical settings, making it invaluable for critical cardiac emergencies.

Precision Formulation for Intravenous Use

TNKase is supplied as a 5 ml clear, colorless solution in a vial. This pharmaceutical-grade injectable delivers Tenecteplase with remarkable accuracy, ensuring consistent efficacy in hospital and clinic use. The product is strictly for intravenous administration, under the guidance of healthcare professionals.

FAQs of Tenecteplase Injection:

Q: How is Tenecteplase Injection administered to patients?

A: Tenecteplase Injection is administered intravenously in hospital or clinic settings, under the supervision of qualified medical personnel. Dosage must be determined by a physician based on individual patient requirements and clinical protocols.

Q: What is the main therapeutic benefit of using Tenecteplase Injection?

A: The primary benefit of Tenecteplase Injection is its ability to dissolve blood clots in coronary arteries, facilitating reperfusion and reducing damage during acute myocardial infarction (heart attack).

Q: When should Tenecteplase Injection be used?

A: Tenecteplase Injection is indicated for immediate use in adults experiencing an acute myocardial infarction, as prescribed by a physician, to restore coronary blood flow and prevent further cardiac complications.

Q: Where should Tenecteplase Injection be stored before use?

A: Tenecteplase Injection should be stored in a cool place, following pharmaceutical storage guidelines, to maintain the integrity and effectiveness of the medication throughout its 18-month shelf life.

Q: What is the process for preparing Tenecteplase Injection for administration?

A: The injection should be inspected to ensure a clear, colorless appearance before administration. The prescribed dosage is then drawn into a syringe and delivered intravenously, strictly adhering to the dosage guidelines provided by the healthcare provider.

Q: Who is eligible to receive Tenecteplase Injection?

A: Tenecteplase Injection is intended for adult patients, as decided by a prescribing physician, primarily in acute care settings. It is not recommended for use in children or without medical supervision.

Tell us about your requirement